These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31477109)

  • 1. Deployment and utilization of next-generation sequencing of Plasmodium falciparum to guide anti-malarial drug policy decisions in sub-Saharan Africa: opportunities and challenges.
    Ishengoma DS; Saidi Q; Sibley CH; Roper C; Alifrangis M
    Malar J; 2019 Sep; 18(1):267. PubMed ID: 31477109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making data map-worthy-enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study.
    Kagoro FM; Allen E; Mabuza A; Workman L; Magagula R; Kok G; Davies C; Malatje G; Guérin PJ; Dhorda M; Maude RJ; Raman J; Barnes KI
    Malar J; 2022 Jun; 21(1):207. PubMed ID: 35768869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018).
    Raman J; Kagoro FM; Mabuza A; Malatje G; Reid A; Frean J; Barnes KI
    Malar J; 2019 Aug; 18(1):280. PubMed ID: 31438951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991-2019.
    Rathmes G; Rumisha SF; Lucas TCD; Twohig KA; Python A; Nguyen M; Nandi AK; Keddie SH; Collins EL; Rozier JA; Gibson HS; Chestnutt EG; Battle KE; Humphreys GS; Amratia P; Arambepola R; Bertozzi-Villa A; Hancock P; Millar JJ; Symons TL; Bhatt S; Cameron E; Guerin PJ; Gething PW; Weiss DJ
    Malar J; 2020 Oct; 19(1):374. PubMed ID: 33081784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring parasite diversity for malaria elimination in sub-Saharan Africa.
    Ghansah A; Amenga-Etego L; Amambua-Ngwa A; Andagalu B; Apinjoh T; Bouyou-Akotet M; Cornelius V; Golassa L; Andrianaranjaka VH; Ishengoma D; Johnson K; Kamau E; Maïga-Ascofaré O; Mumba D; Tindana P; Tshefu-Kitoto A; Randrianarivelojosia M; William Y; Kwiatkowski DP; Djimde AA
    Science; 2014 Sep; 345(6202):1297-8. PubMed ID: 25214619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisinin-Resistant Plasmodium falciparum Malaria.
    Fairhurst RM; Dondorp AM
    Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted deep amplicon sequencing of kelch 13 and cytochrome b in Plasmodium falciparum isolates from an endemic African country using the Malaria Resistance Surveillance (MaRS) protocol.
    L'Episcopia M; Kelley J; Patel D; Schmedes S; Ravishankar S; Menegon M; Perrotti E; Nurahmed AM; Talha AA; Nour BY; Lucchi N; Severini C; Talundzic E
    Parasit Vectors; 2020 Mar; 13(1):137. PubMed ID: 32171330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare mutations in Pfmdr1 gene of Plasmodium falciparum detected in clinical isolates from patients treated with anti-malarial drug in Nigeria.
    Idowu AO; Oyibo WA; Bhattacharyya S; Khubbar M; Mendie UE; Bumah VV; Black C; Igietseme J; Azenabor AA
    Malar J; 2019 Sep; 18(1):319. PubMed ID: 31533729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic diversity and drug resistance surveillance of Plasmodium falciparum for malaria elimination: is there an ideal tool for resource-limited sub-Saharan Africa?
    Apinjoh TO; Ouattara A; Titanji VPK; Djimde A; Amambua-Ngwa A
    Malar J; 2019 Jun; 18(1):217. PubMed ID: 31242921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination.
    Ouji M; Augereau JM; Paloque L; Benoit-Vical F
    Parasite; 2018; 25():24. PubMed ID: 29676250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
    Dlamini SV; Beshir K; Sutherland CJ
    Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions - India and sub-Saharan Africa.
    Arya A; Kojom Foko LP; Chaudhry S; Sharma A; Singh V
    Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():43-56. PubMed ID: 33556786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.
    Talisuna AO; Karema C; Ogutu B; Juma E; Logedi J; Nyandigisi A; Mulenga M; Mbacham WF; Roper C; Guerin PJ; D'Alessandro U; Snow RW
    Lancet Infect Dis; 2012 Nov; 12(11):888-96. PubMed ID: 23099083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spread of artemisinin resistance in Plasmodium falciparum malaria.
    Ashley EA; Dhorda M; Fairhurst RM; Amaratunga C; Lim P; Suon S; Sreng S; Anderson JM; Mao S; Sam B; Sopha C; Chuor CM; Nguon C; Sovannaroth S; Pukrittayakamee S; Jittamala P; Chotivanich K; Chutasmit K; Suchatsoonthorn C; Runcharoen R; Hien TT; Thuy-Nhien NT; Thanh NV; Phu NH; Htut Y; Han KT; Aye KH; Mokuolu OA; Olaosebikan RR; Folaranmi OO; Mayxay M; Khanthavong M; Hongvanthong B; Newton PN; Onyamboko MA; Fanello CI; Tshefu AK; Mishra N; Valecha N; Phyo AP; Nosten F; Yi P; Tripura R; Borrmann S; Bashraheil M; Peshu J; Faiz MA; Ghose A; Hossain MA; Samad R; Rahman MR; Hasan MM; Islam A; Miotto O; Amato R; MacInnis B; Stalker J; Kwiatkowski DP; Bozdech Z; Jeeyapant A; Cheah PY; Sakulthaew T; Chalk J; Intharabut B; Silamut K; Lee SJ; Vihokhern B; Kunasol C; Imwong M; Tarning J; Taylor WJ; Yeung S; Woodrow CJ; Flegg JA; Das D; Smith J; Venkatesan M; Plowe CV; Stepniewska K; Guerin PJ; Dondorp AM; Day NP; White NJ;
    N Engl J Med; 2014 Jul; 371(5):411-23. PubMed ID: 25075834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study.
    Taylor SM; Parobek CM; DeConti DK; Kayentao K; Coulibaly SO; Greenwood BM; Tagbor H; Williams J; Bojang K; Njie F; Desai M; Kariuki S; Gutman J; Mathanga DP; Mårtensson A; Ngasala B; Conrad MD; Rosenthal PJ; Tshefu AK; Moormann AM; Vulule JM; Doumbo OK; Ter Kuile FO; Meshnick SR; Bailey JA; Juliano JJ
    J Infect Dis; 2015 Mar; 211(5):680-8. PubMed ID: 25180240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolates.
    Gendrot M; Foguim FT; Robert MG; Amalvict R; Mosnier J; Benoit N; Madamet M; Pradines B;
    Malar J; 2018 Mar; 17(1):108. PubMed ID: 29530046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy.
    Mohapatra PK; Sarma DK; Prakash A; Bora K; Ahmed MA; Sarma B; Goswami BK; Bhattacharyya DR; Mahanta J
    PLoS One; 2014; 9(9):e105562. PubMed ID: 25184337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination.
    Dhorda M; Amaratunga C; Dondorp AM
    Curr Opin Infect Dis; 2021 Oct; 34(5):432-439. PubMed ID: 34267045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.